DEX

DEXAMETHASONE

Find entries where: DEX

is present as a standalone ligand in 19 entries

Find related ligands:

Chemical Component Summary
Name	DEXAMETHASONE
Synonyms	9A-FLUORO-16BETA-METHYLPREDNISOLONE
Identifiers	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyethanoyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
Formula	C₂₂ H₂₉ F O₅
Molecular Weight	392.461
Type	NON-POLYMER
Isomeric SMILES	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C
InChI	InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1
InChIKey	UREBDLICKHMUKA-CXSFZGCWSA-N

Chemical Details
Formal Charge	0
Atom Count	57
Chiral Atom Count	8
Bond Count	60
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB01234
Name	Dexamethasone
Groups	approved investigational vet_approved
Description	Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Developed in 1957, it is structurally similar to other corticosteroids like [hydrocortisone] and [prednisolone].[A188724] Dexamethasone was granted FDA approval on 30 October 1958.[L10695] In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.[L14318]
Synonyms	Dexamethasone phosphate Dexamethasonum Dexametasona Dexamethasone sodium phosphate 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone Dexaméthasone Dexamethasone 1-Dehydro-16α-methyl-9α-fluorohydrocortisone 16α-Methyl-9α-fluoro-1-dehydrocortisol 9alpha-Fluoro-16alpha-methylprednisolone 9α-Fluoro-16α-methylprednisolone 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
Brand Names	TaperDex 7-day DEXAMETHASONE 6-Day Ratio-dexamethasone Tablets, USP Dioptrol Ointment Sandoz Ciprofloxacin / Dexamethasone Ropidex Pro-dexamethasone - 4 Dexasone 0.5mg Tobradex Dexamethasone-omega Decadron DP HiDex 6-day Apo-dexamethasone Dom-dexamethasone Tablet 4mg Dex-Moxi-Ketor Decadron Decadron Tab 4mg Encor Dec Model 033-443 Imp 0.5mg/imp Ocudex Liq 0.1% Encor Dec Model 033-159 Imp 0.5mg/imp Dexamethasone Sodium Phosphates Ludaxine Dexamethasone Omega Unidose Methedex Zcort Hexadrol Phosphate Inj 4mg/ml Mas Care-pak Dexamethasone Sofracort Ear/eye Ointment Dexamethasone Sod Phosph Inj 10mg/ml USP Ciprodex Odan-trol Odan-dexamethasone Taro-ciprofloxacin/dexamethasone DEXAMETHASONE Sodium Phosphate Dexamethasone Sodium Phosphate Inj USP 4mg/ml Ciprofloxacin and Dexamethasone Viadox Ratio-dexamethasone Dxevo Ciprofloxacin and dexamethasone LoCort 11-Day Neuromaquel Neuroma/Anti-Inflammatory System Sofracort Sterile Ear/eye Ointment TopiDex Decadron Phosphate Inj 4mg/ml Dexamethasone Sodium Phosphate Dexasone 4mg Decadron Phosphate Eye Ear Sol 0.1% Maxitrol Dexasone 0.75mg Neodecadron Eye Ear Soln 0.1% TaperDex 6-day Ozurdex Maxidex Encor Dec Model 033-757 Imp 0.5mg/imp Decadron Tab 0.5mg Cushings Syndrome Diagnostic Mardex 25 Kit R.O.-dexsone Dexamethasone Sod Phos Inj 4mg/ml Neofordex LoCort 7-Day Dexamethasone Npd Neo/Poly-B/Dex Ophth Oint Encor Dec Model 033-856 Imp 0.5mg/imp Netildex Baycadron Dexamethasone 1.5 mg ZoDex PMS-dexamethasone Elixir Tobramycin and Dexamethasone Dexamethasone Sodium Phosphate 0.1% Dexamethasone Intensol PMS-dexamethasone Gati-Dex ZonaCort 11-Day Cortaren Corticosteroid/Anti-Inflammatory System Dexamethsone TaperDex 12-day Zema Pak Hexadrol Phosphate AK-Trol Levodexa Dexamethasone Unidose ZonaCort 7-Day Dexabliss TobraDex DexMoxiKetor PF Encor Dec Model 033-448 Imp 0.5mg/imp Dioptrol Suspension ReadySharp Dexamethasone Dexycu Dexamethasone Sodium Phosphate Injection Sdz Accufix II Dec Model 033-212 Dextenza Dex-Moxi PMS-dexamethasone Sod Phosphate Inj 10mg/ml Tobramycin and dexamethasone 999 Itch Relief DoubleDex Kit Dexlido Kit Tobradex ST PHL-dexamethasone Sandoz Tobramycin / Dexamethasone PMS-dexamethasone Sod Phosphate Dps 1mg/ml Dexamethasone Sodium Phosphate 0.1% / Finasteride 0.1% / Minoxidil 5% Dexamethasone Sodium Phosphate 0.1% / Finasteride 0.1% / Minoxidil 5% / Tretinoin 0.025% Cresophene Liq Dexamethasone Tablets Neo-poly-dex Dexamethasone Sodium Phosphate Injection, USP Neomycin Sulfate, Polymyxin B Sulfate and Dexamethasone Odan-dexamethasone Elixir Dexlido-M Kit PMS-dexamethasone Sod Phosphate Inj 4mg/ml Dexopin Neomycin Polymyxin B Sulfates and Dexamethasone Neomycin and Polymyxin B Sulfates and Dexamethasone ReadySharp Anesthetics plus Dexamethasone Hemady Dex-Moxi PF Dmt Suik Sandoz Dexamethasone Hexadrol Phosphate Inj 10mg/ml
Indication	Dexamethasone and [ciprofloxacin] otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa.[L10698] Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Oral tablets are indicated for the treatment of multiple myeloma.[L10710] An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye.[L10719] Various ophthalmic formulations are indicated for inflammatory conditions of the eye.[L10704,L10707,L10713,L10716,L10722,L10725]
Categories	Adrenal Cortex Hormones Adrenals Agents Causing Muscle Toxicity Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use Alimentary Tract and Metabolism Anti-Acne Preparations Anti-Acne Preparations for Topical Use Anti-Inflammatory Agents Antiemetics Antineoplastic Agents Antineoplastic Agents, Hormonal Autonomic Agents BCRP/ABCG2 Inhibitors BSEP/ABCB11 inducers Central Nervous System Agents Corticosteroid Hormone Receptor Agonists Corticosteroids Corticosteroids for Local Oral Treatment Corticosteroids for Systemic Use Corticosteroids for Systemic Use, Plain Corticosteroids, Dermatological Preparations Corticosteroids, Moderately Potent (Group II) Cytochrome P-450 CYP2A6 Inducers Cytochrome P-450 CYP2B6 Inducers Cytochrome P-450 CYP2B6 Inducers (strength unknown) Cytochrome P-450 CYP2C19 Inducers Cytochrome P-450 CYP2C19 Inducers (strength unknown) Cytochrome P-450 CYP2C8 Inducers Cytochrome P-450 CYP2C8 Inducers (strength unknown) Cytochrome P-450 CYP2E1 Inducers Cytochrome P-450 CYP2E1 Inducers (strength unknown) Cytochrome P-450 CYP3A Inducers Cytochrome P-450 CYP3A Inducers (strong) Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inducers Cytochrome P-450 CYP3A4 Inducers (moderate) Cytochrome P-450 CYP3A4 Inducers (strong) Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (weak) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Inducers Cytochrome P-450 CYP3A5 Inducers (moderate) Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A7 Inducers Cytochrome P-450 CYP3A7 Inducers (strength unknown) Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dermatologicals Experimental Unapproved Treatments for COVID-19 Fused-Ring Compounds Gastrointestinal Agents Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Hyperglycemia-Associated Agents Immunosuppressive Agents Inducers of Drug Clearance Nasal Preparations OAT3/SLC22A8 Substrates Ophthalmological and Otological Preparations Ophthalmologicals Otologicals P-glycoprotein inducers P-glycoprotein inhibitors P-glycoprotein substrates Peripheral Nervous System Agents Pregnadienes Pregnadienetriols Pregnanes Sensory Organs Steroids Steroids, Fluorinated Stomatological Preparations Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins Vasoprotectives
ATC-Code	R01AD53 D07XB05 R01AD03 D10AA03 S01CB01 S02CA06 S03CA01 C05AA09 S01CA01 D07CB04 H02AB02 S01BA01 A01AC02 S03BA01 D07AB19 S02BA06
CAS number	50-02-2

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Glucocorticoid receptor	MDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAV...	unknown	agonist
Nuclear receptor subfamily 0 group B member 1	MAGENHQWQGSILYNMLMSAKQTRAAPEAPETRLVDQCWGCSCGDEPGVG...	unknown	stimulator
Annexin A1	MAMVSEFLKQAWFIENEEQEYVQTVKSSKGGPGSAVSPYPTFNPSSDVAA...	unknown	agonist
Nitric oxide synthase, inducible	MACPWKFLFKTKFHQYAMNGEKDINNNVEKAPCATSSPVTQDDLQYHNLS...	unknown	negative modulator
Nuclear receptor subfamily 1 group I member 2	MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATG...	unknown	agonist
Corticosteroid 11-beta-dehydrogenase isozyme 2	MERWPWPSGGAWLLVAARALLQLLRSDLRLGRPLLAALALLAALDWLCQR...	unknown	substrate
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate,inhibitor,inducer
Corticosteroid 11-beta-dehydrogenase isozyme 1	MAFMKKYLLPILGLFMAYYYYSANEEFRPEMLQGKKVIVTGASKGIGREM...	unknown	substrate
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate,inducer
Cytochrome P450 3A7	MDLIPNLAVETWLLLAVSLILLYLYGTRTHGLFKKLGIPGPTPLPFLGNA...	unknown	substrate,inducer
Steroid 17-alpha-hydroxylase/17,20 lyase	MWELVALLLLTLAYLFWPKRRCPGAKYPKSLLSLPLVGSLPFLPRHGHMH...	unknown	inhibitor
Cytochrome P450 1A1	MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG...	unknown	inhibitor,inducer
Cytochrome P450 2A6	MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLN...	unknown	inducer
Cytochrome P450 2B6	MELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRG...	unknown	inducer
Cytochrome P450 2C19	MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...	unknown	inducer
Cytochrome P450 2C8	MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...	unknown	inducer
Cytochrome P450 2E1	MSALGVTVALLVWAAFLLLVSMWRQVHSSWNLPPGPFPLPIIGNLFQLEL...	unknown	inducer
Cytochrome P450 3A43	MDLIPNFAMETWVLVATSLVLLYIYGTHSHKLFKKLGIPGPTPLPFLGTI...	unknown	inducer
Cytochrome P450 4A11	MSVSVLSPSRLLGDVSGILQAASLLILLLLLIKAVQLYLHRQWLLKALQQ...	unknown	inducer
Cytochrome P450 11B1, mitochondrial	MALRAKAEVCMAVPWLSLQRAQALGTRAARVPRTVLPFEAMPRRPGNRWL...	unknown	inhibitor
Serum albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	binder
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate,inhibitor,inducer
Solute carrier family 22 member 8	MTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCR...	unknown	substrate
Bile salt export pump	MSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQL...	unknown	inducer
Canalicular multispecific organic anion transporter 1	MLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGYLWLLAPWQLLH...	unknown	inducer
ATP-binding cassette sub-family G member 2	MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKS...	unknown	inhibitor
Solute carrier organic anion transporter family member 1A2	MGETEKRIETHRIRCLSKLKMFLLAITCAFVSKTLSGSYMNSMLTQIERQ...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682